Cerebral Palsy Hip Outcomes Project - International Multi-centre Study
Outcomes of Hip Interventions for Children With Cerebral Palsy - An International Multi-centre Prospective Comparative Cohort Study
1 other identifier
observational
500
10 countries
27
Brief Summary
The primary purpose of the project is to evaluate the effectiveness of different intervention strategies to prevent or relieve symptoms associated with hip instability in children with severe cerebral palsy, using the validated Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD©) questionnaire as the primary outcome measure of health-related quality of life for this population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2014
Longer than P75 for all trials
27 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 13, 2013
CompletedFirst Posted
Study publicly available on registry
November 19, 2013
CompletedStudy Start
First participant enrolled
June 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2022
CompletedFebruary 11, 2021
February 1, 2021
6.8 years
November 13, 2013
February 9, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
CPCHILD questionnaire: Total Score (0-100)
The primary outcome measure will be based at the 12 month assessment. The CPCHILD questionnaire is a validated outcome measure of health-related quality of life specifically developed for children with severe, non-ambulant cerebral palsy (GMFCS level IV and V) to evaluate the effectiveness of different treatment options.
Change from baseline to 12 months after treatment
Secondary Outcomes (5)
CPCHILD Questionnaire: Total Score (0-100)
Change from baseline to 24 months after treatment
Reimer's Migration Percentage (MP)
Change from baseline to 24 months after treatment
Acetabular Index (AI) in degrees
Change from baseline to 24 months after treatment
Morphological Hip Classification in Cerebral Palsy (MHC)
Change from baseline to 24 months after treatment
CPCHILD Questionnaire: Subscale Scores (0 - 100)
Change from baseline to 24 months after treatment
Other Outcomes (1)
Adverse Events and Complications
Adverse events will be recorded up to 24 months after treatment
Study Arms (5)
A. "Natural" History or Watchful Waiting
B. Serial Botulinum Toxin Injections +/- Abduction Bracing
C. Adductor (+/- psoas) Muscle Releases Alone
D. Hip Reconstructive Surgery
E. Salvage Hip Surgery
Eligibility Criteria
Children with severe, non-ambulant cerebral palsy (GMFCS level IV and V) and their parent / primary caregiver will be enrolled in the study.
You may qualify if:
- Children with a working diagnosis of cerebral palsy or cerebral palsy-like condition
- Between 2 to 18 years of age
- Has a migration percentage ≥ 30%
- Non-ambulatory; the primary mode of mobility is a wheelchair
- Parent/primary caregiver must understand one of the languages in which the CPCHILD has been translated, culturally adapted and validated.
You may not qualify if:
- History of prior hip surgery
- Received botulinum toxin injection within the previous 3 months. Recruitment will be delayed until at least 3 months after prior botulinum toxin injection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (27)
Shriners Hospitals for Children - Northern California
Sacramento, California, United States
Children's Hospital Colorado
Aurora, Colorado, United States
Alfred I. Dupont Institute
Wilmington, Delaware, United States
Children's Hospital Boston
Boston, Massachusetts, United States
Gillette Children's Specialty Healthcare
Saint Paul, Minnesota, United States
Children's of Mississippi
Jackson, Mississippi, United States
Hospital for Special Surgery
New York, New York, United States
New York-Presbyterian Morgan Stanley Children's Hospital
New York, New York, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
Royal Children's Hospital
Melbourne, Victoria, Australia
BC Children's Hospital
Vancouver, British Columbia, Canada
Holland Bloorview Kids Rehabilitation Hospital
Toronto, Ontario, Canada
The Hospital for Sick Children
Toronto, Ontario, Canada
Shriners Hospital for Children - Canada
Montreal, Quebec, Canada
Aarhus University Hospital
Aarhus, Denmark
Safra Hospital for Children
Tel Litwinsky, Ramat Gan, Israel
Starship Children's Hospital of New Zealand
Auckland, New Zealand
K. Marcinkowski Medical University
Poznan, Poland
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
Lund University Hospital
Lund, Sweden
Astrid Lindgren's Children's Hospital
Stockholm, Sweden
University Hospitals Coventry & Warwickshire NHS Trust
Coventry, England, United Kingdom
Alder Hey Children's NHS Foundation Trust
Liverpool, England, United Kingdom
Royal National Orthopaedic Hospital
London, England, United Kingdom
The Royal London and St. Bartholomew's Hospitals
London, England, United Kingdom
Nuffield Orthopaedic Centre NHS Trust
Oxford, England, United Kingdom
Royal Hospital for Sick Children
Edinburgh, Scotland, United Kingdom
Related Publications (2)
Narayanan UG, Fehlings D, Weir S, Knights S, Kiran S, Campbell K. Initial development and validation of the Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD). Dev Med Child Neurol. 2006 Oct;48(10):804-12. doi: 10.1017/S0012162206001745.
PMID: 16978459BACKGROUNDMiller SD, Juricic M, Fajardo N, So J, Shore BJ, Narayanan UG, Mulpuri K. Variability in Postoperative Immobilization and Rehabilitation Following Reconstructive Hip Surgery in Nonambulatory Children With Cerebral Palsy. J Pediatr Orthop. 2021 Aug 1;41(7):e563-e569. doi: 10.1097/BPO.0000000000001850.
PMID: 33999564DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dr. Unni Narayanan, MBBS, MSc, FRCSC
Holland Bloorview Kids Rehab and The Hospital for Sick Children, Toronto, Canada
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 13, 2013
First Posted
November 19, 2013
Study Start
June 1, 2014
Primary Completion
April 1, 2021
Study Completion
April 1, 2022
Last Updated
February 11, 2021
Record last verified: 2021-02